Skip to content
Catalyst

methylphenidateFinding

Methylphenidate has no detected effect on health-related quality of life

no difference foundVery limited evidenceFinding

01 · The sentence it was drawn from

“Methylphenidate may improve teacher-rated general behaviour versus placebo (SMD -0.62, 95% CI -0.91 to -0.33; I² = 68%; 7 trials 792 participants; very low-certainty evidence), but may not affect quality of life (SMD 0.40, 95% CI -0.03 to 0.83; I² = 81%; 4 trials, 608 participants; very low-certainty evidence).”
Quoted verbatim from Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
This finding among the 14 findings on its endpoint

methylphenidate

Health-related quality of life

no difference found

Effect as reported

0.4standardised mean difference

CI −0.03 to 0.83

Who
n = 608 · children and adolescents with ADHD; secondary outcome (quality of life), instrument not named by the review
Dose studied
not reported

Very limited evidencePMID 41342306 · 2025

02 · The study

Study
meta-analysis
Participants
608
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3PBN173N4J9570NNXS0BE1G